290
Participants
Start Date
December 1, 2015
Primary Completion Date
August 18, 2019
Study Completion Date
October 18, 2019
AB103 0.5 mg/kg
NaCl 0.9%
Staten Island University Hospital-Northwell Health, Staten Island
Albany Medical Center, Albany
Erie County Medical Center-Affliate of SUNYat Buffalo, Buffalo
University of Pittsburgh Medical Center, Pittsburgh
The Pennsylvania State University and The Milton S. Hershey Medical Center, Hershey
St. Luke's University Health Network, Bethlehem
The Trauma Center at PENN, Philadelphia
Thomas Jefferson University, Philadelphia
Washington Hospital Center, Washington D.C.
University of Maryland R Adams Cowley Shock Trauma Center, Baltimore
Banner University Medical Center, Tucson
East Carolina University, Greenville
Carolinas Medical Center, Charlotte
Emory University at Grady Memorial Hospital, Atlanta
Augusta University Health, Augusta
UF Health Shands Hospital, Gainesville
Ryder Trauma Center/Jackson Memorial Hospital, Miami
University of Alabama at Birmingham, Birmingham
Vanderbilt University Medical Center, Nashville
University of Kentucky, Lexington
The Ohio State University, Columbus
The MetroHealth System, Cleveland
St Elizabeth Youngstown Hospital, Youngstown
University of Cincinnati Medical Center (UCMC), Cincinnati
Wright State University & Premier Health Clinical Trials Research Alliance, Dayton
University of Michigan, Ann Arbor
Wayne State University-Detroit Receiving Hospital, Detroit
Henry Ford Health System, Detroit
Wayne State University-Sinai Grace Hospital, Detroit
University of Iowa Hospital and Clinics, Iowa City
Medical College of Wisconsin-Froedtert Hospital, Milwaukee
Hennepin County Medical Center, Minneapolis
Fairview Southdale Hospital, Edina
University of Minnesota Medical Center-Fairview, Minneapolis
St Louis University, St Louis
University of Missouri, Columbia
LSU Health Science Center, New Orleans
Our Lady of the Lake Regional Medical Center, Baton Rouge
Baton Rouge General Hospital, Baton Rouge
University of Arkansas for Medical Sciences, Little Rock
John Peter Smith Health Network, Fort Worth
Scott and White Medical Center, Temple
Baylor College of Medicine-Ben Taub Hospital, Houston
University of Texas Health Science Center at San Antonio, San Antonio
Texas Tech University Health Sciences Center at El Paso, El Paso
University of Colorado Hospital, Denver
UCH-Memorial Health System, Colorado Springs
Maricopa Medical Center, Phoenix
Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Los Angeles
UCSD Medical Center, San Diego
Loma Linda University Medical Center, Loma Linda
University of California, Davis Medical Center, Sacramento
Legacy Emanuel Hospital, Portland
Oregon Health and Science University, Portland
Harborview Medical Center, Seattle
Capital Health System, Inc., Trenton
Yale New Haven Hospital, New Haven
Maine Medical Center, Portland
Massachusetts General Hospital, Boston
Brigham and Women's Hospital, Boston
Cooper University Hospital, Camden
Hộpital Estaing-CHU de Clermont-Ferrand, Clermont-Ferrand
Hộpital Henri Mondor, Créteil
Hôpital Bicêtre, Le Kremlin-Bicêtre
Robert Salengro Hopital-CHRU Lille, Lille
CHU de Limoges, Limoges
Hôpital Edouard Herriot, Lyon
CHRU Nancy, Hôpital Central, Nancy
CHU de Nimes, Nîmes
Hôpital de la Source, CHR Orleans, Orléans
CHRU Bretonneau, Tours
Lead Sponsor
Biomedical Advanced Research and Development Authority
FED
Atox Bio Ltd
INDUSTRY